Related Experiment Video

Updated: Jun 11, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K

A protracted war against cancer drug resistance

Yuan Tian1, Xiaowei Wang2, Cong Wu2

  • 1School of Lifesciences, Shanghai University, 333 Nanchen Road, Shanghai, 200444, P.R. China.

Cancer Cell International
|September 28, 2024
PubMed

Insights

Cancer drug resistance and tumor relapse limit therapies. Novel approaches like PROTAC technology, immunotherapy, and nanomedicine offer new strategies to overcome resistance and improve cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer therapies face significant limitations due to acquired drug resistance and tumor recurrence.
  • Understanding the molecular mechanisms of drug resistance is crucial for predicting clinical outcomes and developing effective treatments.

Purpose of the Study:

  • To review key challenges and mechanisms associated with cancer drug resistance.
  • To provide a framework for understanding how cancers develop resistance to therapeutic agents.
  • To highlight emerging technologies and conceptual shifts for overcoming drug resistance.

Main Methods:

  • Literature review focusing on cancer drug resistance mechanisms.
  • Analysis of advancements in therapeutic technologies including PROTAC, immunotherapy, and nanomedicine.
  • Exploration of novel treatment concepts leveraging tumor subclone dynamics.

Main Results:

  • Identified common pathways and mechanisms by which cancers acquire resistance to anticancer drugs.
  • Highlighted the potential of proteolysis targeting chimera (PROTAC) technology, immunotherapy, nanomedicine, and real-time drug response monitoring.
  • Emphasized the strategic importance of exploiting the interplay between drug-sensitive and drug-resistant cancer cell populations.

Conclusions:

  • Despite significant progress, overcoming cancer drug resistance remains a complex and ongoing challenge.
  • Advancements in therapeutic technologies and treatment strategies offer promising avenues to combat resistance.
  • Further research is essential to fully realize the potential of these new approaches in the fight against cancer.
Keywords:
Cancer drug resistanceCancer evolutionCancer stem cellsIndividualized medicineYin-Yang balance

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489